Metraipolis › archive › dc_5ba5fbb3ebe1

Targeted therapy plus chemotherapy for advanced or metastatic triple-negative breast cancer: a PRISMA 2020 systematic review and meta-analysis — Europe PMC PMID:42666138

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42666138
DOI
10.3389/fonc.2026.1903922
License (as archived)
solo-consultazione
Archived
2026-10-16T14:08:27.540Z
SHA-256 of the archived text
58ba2e54c9cbf0d386d9a7d66fb8156bdc4dab51b10889ecf0e8a7463fe12904
Stable URL of this page
https://metraipolis.com/documento/dc_5ba5fbb3ebe1

How to cite

Targeted therapy plus chemotherapy for advanced or metastatic triple-negative breast cancer: a PRISMA 2020 systematic review and meta-analysis — Europe PMC PMID:42666138 — Europe PMC (en), https://europepmc.org/article/MED/42666138 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5ba5fbb3ebe1 (Metraipolis archive dc_5ba5fbb3ebe1, sha256 58ba2e54c9cbf0d386d9a7d66fb8156bdc4dab51b10889ecf0e8a7463fe12904)
BibTeX
@misc{dc5ba5fbb3ebe1,
  title = {Targeted therapy plus chemotherapy for advanced or metastatic triple-negative breast cancer: a PRISMA 2020 systematic review and meta-analysis — Europe PMC PMID:42666138},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42666138},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5ba5fbb3ebe1; sha256 58ba2e54c9cbf0d386d9a7d66fb8156bdc4dab51b10889ecf0e8a7463fe12904},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42666138. Agents can read the archived copy with the MCP tool read_document.